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Background. Previous studies indicated sleep-disordered breathing (SDB) is associated with cardiovascular disease (CVD).
Systemic inﬂammation is recognized as a risk factor for CVD. Studies examining SDB and inﬂammation are limited. Methods.W e
studied sleep duration, snoring, snorting, and daytime sleepiness, and an additive SDB score. The main outcome was a C-reactive
protein (CRP) of >1mg/dL. Results. Snoring, snorting, daytime sleepiness, and sleeping >7o r<7 hours, and the additive score
were signiﬁcantly associated with high CRP. The additive score was not associated in men but moderately associated in women
in a multivariable model adjusting for age, gender, race/ethnicity, education, smoking, hypertension, alcohol intake, physical
activity, body mass index, depression, diabetes, hypertension, and total cholesterol (P-interaction= 0.42). For race/ethnicity,
the association was strongest in Mexican Americans/others, modest in Non-Hispanic whites, and absent in Non-Hispanic blacks
(P-interaction= 0.07). Conclusions. The association between SDB and high CRP was present mainly in women and Mexican
Americans, implying SDB has a residual, independent association with inﬂammation after controlling for lifestyle and metabolic
risk factors like BMI, physical activity, depression, diabetes, and cholesterol.
1.Introduction
Sleep-disordered breathing (SDB) is a common, chronic
disorderinwhichthereissleep-relatedrepeatedupperairway
collapse resulting in episodes of hypoxemia and arousal
[1]. Nationwide, SDB aﬀects approximately 12–18 million
people, nearly 4% of the population [2]. SDB is described as
markedly undiagnosed [3]( e s p e c i a l l yi nw o m e n[ 4]). SDB
is a public health concern as it has been associated with
cardiovascular disease (CVD) [5], motor vehicle crashes,
[3, 6, 7] neuropsychological deﬁcits [8], and mortality [9].
Recent US and Japanese studies have shown an associ-
ation between SDB markers and C-reactive protein (CRP),
a biomarker of inﬂammation and predictor of future risk
of CVD [10–13]. For example, strong positive associations
occurred in a study of 69 healthy men, controlling for age,
BMI, waist circumference, and percent body fat [1]. Also,
a study of 18 men and 4 women showed elevated CRP
levels with newly diagnosed obstructive sleep apnea in a
multivariate analysis controlling for age, sex, BMI, smoking,
alcohol, LDL, and HDL [10] .As t u d yo f3 0m e nw i t hn e w l y
diagnosed obstructive sleep apnea and 14 obese controls
showed higher CRP in those with obstructive sleep apnea
than the obese controls. However, the studies were small in
scope [10–13]. A larger study of 316 Japanese men showed
SDBandCRPtobeassociated,howeverittrendedtoahigher
association in those who were nonoverweight [14]. Also, not
all studies have shown an association between SDB and CRP.
The Wisconsin Sleep Cohort study of 907 adults aged 30–60,
including407women,indicatedthatasigniﬁcantassociation
of CRP and SDB was not signiﬁcant after adjusting for age,
sex, and BMI [15].
Additionally, studies examining the association between
SDBandinﬂammatorymarkersbygenderandrace/ethnicity2 International Journal of Vascular Medicine
are limited and have conﬂicting results. In a study of
239 participants, including 83 women, where the statistical
analysis was stratiﬁed by gender, the results indicated that
SDB indices did not contribute to high CRP for men [16].
However, a study of 49 participants, including 12 women,
showed that SDB markers were independently associated
with high CRP [17]. Therefore, the role of gender in the
association of self-reported SDB and CRP requires clariﬁ-
cation. In a similar manner, although non-Hispanic Blacks
and Hispanics have a disproportion of sleep disturbances
[18], no examination of the markers of snoring, snorting,
daytimesleepiness,andsleepdurationandCRPwasavailable
in the literature. Therefore, we examined the association of
markers of self-reported SDB and CRP stratiﬁed by gender
andrace/ethnicityinalarge,nationallyrepresentativesample
of US adults, after controlling for the main confounding
factors.
2. Methods
This study utilized data from the National Health and
Nutrition Examination Survey (NHANES) 2005-06 and
2007-08. The study design and study methodology of
the NHANES are available in detail elsewhere [19, 20].
Summarily, the NHANES is an on-going program of surveys
assessing the health and nutrition of adults and children in
the U.S by way of a stratiﬁed, multistage, probability sample
representingtheUScivilian,noninstitutionalizedpopulation
[19]. The survey uses interviews, physical examinations, and
laboratory measurements of participants selected by coun-
ties, blocks, households, and individuals in the household
with oversampling of non-Hispanic Blacks and Mexican
Americans [19].
CRP data was obtained for individuals aged twenty
and above; therefore our study was restricted to those
participants. Out of 20,497 participants in NAHNES survey,
there were 10,914 subjects who were ≥20 years of age. We
further excluded participants who were pregnant (n = 393),
had prevalent CVD (n = 1,275), had missing information
on SDB variables (n = 2,107), CRP, and other covariates
(n = 651) included in the multivariable model. This resulted
in 6,488 participants included in the ﬁnal analysis.
2.1. Outcome of Interest: High CRP. High CRP level was the
outcome of interest. High CRP was deﬁned as >1mg/dL,
consistent with American Heart Association/Centers for
Disease Control & Prevention (AHA/CDC) guidelines for
identifying subjects with moderate/high risk of CVD [21].
Serum CRP was measured using latex-enhanced nephelom-
etry. Details of the laboratory collection, processing, and
analysis are available in the laboratory procedures manual
[19, 20].
2.2. Assessment of Exposure: SDB. The NHANES included
a series of interview questions regarding sleep habits which
were used to assess SDB. The questions included: “How
much sleep do you usually get at night and on weekdays
or workdays?”; “In the past 12 months, how often did you
snore while you were sleeping?”; “In the past 12 months,
how often did you snort, gasp, or stop breathing while you
were asleep?”; “In the past month, how often did you feel
excessively or overly sleepy during the day?” We developed
four sleep variables from the questions: sleep duration;
snoring; snorting; daytime sleepiness. Our categories for
sleep duration were coded in hours into ≤5, 6, 7, 8,
and ≥9; sleepiness, snorting, and snoring into “never or
rare,” “sometimes” (2–4 times/week), and “often” or “almost
always” (5 or more times/week).
We also developed an additive summary SDB clustering
score which was a composite of the four sleep variables after
dichotomizingthevariablesutilizingclinicalsigniﬁcanceand
previous literature [22–24]. In creating the four dichoto-
mous SDB variables, a score of 1 was assigned if there was
a report of sleep duration of ﬁve hours or less, snoring at
least 3-4 nights/week, snorting at least 3-4 nights/week, and
having daytime sleepiness ofatleast5times/month, and zero
otherwise. These individual scores were then added to create
the summary SDB clustering score. Therefore the additive
summary SDB clustering score had a range of 0–4. A score
of 0 reﬂected no sleep disturbances. A score of 4 indicated
the simultaneous presence of all 4 sleep disturbances.
2.3.AssessmentofCovariates. TheNHANEShomeinterview
had questions concerning age, gender, race/ethnicity, smok-
ing status, alcohol intake (in grams/day), educational level,
physical activity, body mass index, depression, diabetes, and
hypertension. The educational level categorization was less
than high school graduation, high school graduation, and
more than high school graduation. The deﬁnition used for
never smoking was the smoking of less than 100 cigarettes
during one’s lifetime. Former smokers were deﬁned as those
who had a lifetime smoking history of 100 or more cigarettes
and were no longer smoking. Current smokers were deﬁned
as those who had a lifetime smoking history of 100 or more
cigarettes and continued to smoke. Current alcohol drinking
was deﬁned as the consumption of one or more alcoholic
drinks in the previous 12 months. Moderate physical activity
was deﬁned as participating in moderate-intensity sports,
ﬁtness, or recreations which resulted in a small heart and
breathing rate increase. These activities included at least 10
minutes of brisk walking, cycling, swimming, or golf per
week.
The medical examination center (MEC) examination
provided anthropometric, physical, and laboratory evalua-
tions. Body mass index (BMI) was determined as weight in
kilograms divided by height in meter squared. Depression
was deﬁned as feeling down, depressed, or hopeless within
the previous two weeks with a duration of more than half
of the days or nearly every day. Three blood pressure mea-
surements were taken with a mercury sphygmomanometer.
The mean results were used for the systolic and diastolic
pressures.Ifthemeansystolicbloodpressurewas140mmHg
or above or the diastolic blood pressure was 90mmHG
or above, or the participant reported taking blood-pressure
reducing medications, he or she was considered to have
hypertension.International Journal of Vascular Medicine 3
Table 1: Baseline characteristics of the study population.
Characteristics Mean values ± standard error (SE)
or percentages (number)
Total Number 6488
Women (%) 3158 (50.48%)
Age (years) 44.75 ±0.45
Race/ethnicity (%)
Non-Hispanic Whites 3211 (72.63%)
Non-Hispanic Blacks 1309 (10.04%)
Mexican Americans 1202 (7.94%)
Others 766 (9.40%)
Education categories (%)
Below high school 1733 (16.87%)
High school 1576 (24.48%)
Above high school 3179 (58.64%)
Smoking (%)
Never smoker 3453 (52.80%)
Former smoker 1539 (23.62%)
Current smoker 1496 (23.59%)
Alcohol intake, current
drinker (%) 4444 (74.34%)
Moderate physical activity (%) 3017 (53.59%)
Body mass index (%)
Normal weight 1970 (33.17%)
Overweight 2271 (33.89%)
Obese 2247 (32.94%)
Depression (%) 414 (5.12%)
Diabetes (%) 828 (8.92%)
Total cholesterol (mg/dL) 0.38 ±0.01
T o t a ls e r u mc h o l e s t e r o ll e v e l sw e r ed e t e r m i n e de n z y m a t -
ically using the Roche Hitachi 717 in 2005, Roche Hitachi
717 and 912 in 2006, and the Roche Modular P chemistry
analyzer in 2007-2008. The details of blood collection,
processing, and analysis are available in the laboratory
procedures manuals [19, 20].
2.4. Statistical Analysis. Characteristics of the study partic-
ipants by high CRP (levels > 1mg/dL) were determined
utilizing the chi square test or analysis of variance, as appro-
priate. We evaluated the associations between sleep variables
(sleep duration, snoring, snorting, daytime sleepiness, and
the ad hoc additive SBD clustering summary score) and CRP
with two multivariable models. The ﬁrst model adjusted
for age (years), gender (male, female), race/ethnicity (non-
Hispanic whites, non-Hispanic blacks, Mexican Americans,
others), education (below high school, high school, above
high school), smoking (never smoker, former smoker,
current smoker), hypertension (absent, present), and alco-
hol intake (absent, present). In the second model we
added physical activity (moderate physical activity), body
mass index (obese, nonobese), depression (absent, present),
diabetes (absent, present), and total cholesterol (mg/dL).
In these analyses, we used linear regression models when the
continuousCRPlevelwasthedependentvariableandlogistic
regression models when the categorical high CRP (levels >
1mg/dL) was the outcome variable. We performed tests for
trend with the individual sleep variables and the summary
score as an ordinal variable in the multivariable models.
We examined the consistency of associations with subgroup
analysis stratiﬁed by gender and race/ethnicity. The analyses
were weighted to adjust for the unequal probabilities of
selection,oversampling,andnonresponsebyusingSUDAAN
(version 8.0; Research Triangle Institute, Research Triangle
Park, NC) and SAS (version 9.1.; SAS Institute, Cary, NC)
software.
3. Results
The baseline characteristics of the study population are
presented in Table 1. The study population was primarily
white (72.6%), educated (58.6% were educated above high
school), middle aged (44.8 years), and current drinkers of
alcohol (74.3%). Normal weight, overweight, and obesity
were equally distributed. Approximately one-half (52.8%)
were never smokers, and the remainder was equally dis-
tributed as former smokers (23.6%) and current smokers
(23.6%). Depressionwasreported in5.1% ofthepopulation,
and diabetes was present in 8.9%.
Table 2 presents the ORs for the association between
markers of SDB and the presence of CRP levels > 1mg/dL.
For sleep duration, compared with people who slept 7 hours
(referent category), longer and shorter durations of sleeping
had higher odds of having CRP levels > 1mg/dL in both age-
sex-adjusted and multivariable-adjusted models, although
the multiple covariates in the latter model attenuated the
association.
Similarly, for snoring, compared with 0–2 nights of snor-
ing per week (referent category), snoring more frequently
was associated with higher odds of having CRP levels >
1mg/dL. We observed that compared to the age-sex and
the multivariable model 1, there was attenuation of the
association in the multivariable model 2, which additionally
adjusted for physical activity, body mass index, depression,
diabetes, hypertension, and total cholesterol.
For snorting, compared with snorting 0–2 nights per
week (referent category), snorting more frequently was
associated with higher odds of having CRP levels > 1mg/dL.
Here, we observed that even though there was a positive
association in the age-sex and the multivariable model
1, with additional adjustment for physical activity, body
mass index, depression, diabetes, hypertension, and total
cholesterol in the multivariable model 2, the association was
substantially attenuated and no longer present.
For daytime sleepiness, compared with 0-1 occurrences
ofdaytime sleepiness per month (referentcategory),daytime
sleepiness was associated with higher odds of having CRP
levels > 1mg/dL. We observed a positive association in the
age-sex, and the multivariate model 1, which attenuated in
the multivariable model 2.4 International Journal of Vascular Medicine
Table 2: Association between sleep-disordered breathing variables and C-reactive protein levels > 1mg/dL.
Sleep variables Sample size
(hypertension %)
Age, sex adjusted
odds ratio (95% CI)
Multivariable-model 1∗
odds ratio (95% CI)
Multivariable-model 2†
odds ratio (95% CI)
Sleep duration (hours)
≤5hrs 120 (11.4%) 1.76 (1.23–2.53) 1.57 (1.11–2.23) 1.35 (0.93–1.97)
6hrs 138 (8.1%) 1.18 (0.81–1.73) 1.13 (0.77–1.67) 1.11 (0.76–1.63)
7hrs 141 (7.0%) 1 (referent) 1 (referent) 1 (referent)
8hrs 157 (8.3%) 1.16 (0.87–1.54) 1.14 (0.85–1.52) 1.15 (0.84–1.58)
≥9hrs 49 (10.9%) 1.50 (0.96–2.34) 1.44 (0.93–2.22) 1.61 (1.03–2.52)
P-trend 0.1275 0.3175 0.9488
Snoring (nights/week)
0–2 247 (6.59%) 1 (referent) 1 (referent) 1 (referent)
3-4 130 (9.33%) 1.57 (1.20–2.05) 1.53 (1.17–2.01) 1.23 (0.93–1.62)
≥5 228 (0.34%) 1.98 (1.55–2.53) 1.90 (1.48 2.44) 1.26 (0.99–1.61)
P-trend <0.0001 <0.0001 0.0619
Snorting (nights/week)
0–2 509 (8.08%) 1 (referent) 1 (referent) 1 (referent)
3-4 44 (9.61%) 1.37 (0.93–2.03) 1.32 (0.89–1.95) 1.09 (0.73–1.64)
≥5 52 (11.94%) 1.72 (1.11–2.65) 1.64 (1.07–2.52) 1.06 (0.66–1.69)
P-trend 0.0054 0.0098 0.7288
Daytime sleepiness
(times/month)
0-1 323 (7.57%) 1 (referent) 1 (referent) 1 (referent)
2–4 154 (8.09%) 1.07 (0.85–1.36) 1.08 (0.84–1.38) 1.02 (0.78–1.33)
≥5 128 (11.54%) 1.53 (1.19–1.98) 1.47 (1.15–1.89) 1.27 (0.96–1.68)
P-trend 0.0026 0.0051 0.1289
Sleep summary score
0 170 (6.13%) 1 (referent) 1 (referent) 1 (referent)
1 234 (8.45%) 1.52 (1.14–2.03) 1.470 (1.10–1.97) 1.16 (0.87–1.55)
2 148 (11.40%) 2.23 (1.68–2.95) 2.097 (1.57–2.80) 1.47 (1.07–2.02)
≥3 53 (13.46%) 2.67 (1.89–3.78) 2.400 (1.69–2.42) 1.40 (0.95–2.08)
P-trend <0.0001 <0.0001 0.0228
∗Model 1: adjusted for age (years), gender (male, female), race/ethnicity (non-Hispanic whites, non-Hispanic blacks, Mexican Americans, and others),
education (below high school, high school, and above high school), smoking (never smoker, former smoker, and current smoker), and alcohol intake (absent,
present).
†Model 2: adjusted for age (years), gender (male, female), race/ethnicity (non-Hispanic whites, non-Hispanic blacks, Mexican Americans, and others),
education (below high school, high school, and above high school), smoking (never smoker, former smoker, and current smoker), alcohol intake (absent,
present), physical activity (moderate physical activity), body mass index (obese, nonobese), depression (absent, present), diabetes (absent, present), and total
cholesterol (mg/dL).
We also derived an additive summary SDB clustering
score by dichotomizing the SDB variables and taking their
sum, resulting in a score ranging from 0 (no or minimal
markers of sleep disorder) to 4 (the co-occurrence of all
of the markers of sleep disorder). For the SDB clustering
score, compared with a score of 0 (referent category), a
higher sleep clustering score was associated with higher
odds of having CRP levels > 1mg/dL. The positive asso-
ciation persisted in the age-sex model and multivariable
model 1, but was attenuated in the multivariable model 2
(Table 2).
Subsequently, we examined the association between the
summary SDB clustering score and the odds of having
CRP levels > 1mg/dL within subgroup analyses of gender
(Table 3) and race-ethnicity (Table 4). For the subgroup
analysis by gender (Table 3), we found that higher sum-
mary SDB score was only weakly associated in men
but moderately associated in women in the multivariable
model 2 (P-interaction = 0.42). For the subgroup analysis
by race/ethnicity (Table 4), the magnitude of association
appeared to be the strongest in Mexican Americans and
others, modestly in Non-Hispanic whites, and absent in
Non-Hispanic blacks (P-interaction = 0.07).
4. Discussion
In a large multiethnic sample of US adults, we found that
markers of SDB, including short sleep duration (<7h o u r s ) ,International Journal of Vascular Medicine 5
Table 3: Association between sleep variables and C-reactive protein levels > 1mg/dL, by gender.
Sleep summary score Sample size
(hypertension %)
Age-adjusted odds
ratio (95% CI)
Multivariable-model 1∗
odds ratio (95% CI)
Multivariable-model 2†
odds ratio (95% CI)
Men
0 61 (4.30%) 1 (referent) 1 (referent) 1 (referent)
1 90 (5.49%) 1.27 (0.83–1.94) 1.20 (0.79–1.84) 1.12 (0.75–1.66)
2 62 (7.82%) 1.84 (1.14–2.97) 1.71 (1.04–2.81) 1.44 (0.89–2.34)
≥3 17 (7.42%) 1.80 (0.96–3.37) 1.56 (0.84–2.88) 1.24 (0.65–2.35)
P-trend 0.0084 0.0269 0.2038
Women
0 109 (7.44%) 1 (referent) 1 (referent) 1 (referent)
1 144 (11.69%) 1.64 (1.10–2.46) 1.60 (1.07–2.39) 1.15 (0.77–1.72)
2 86 (16.31%) 2.42 (1.66–3.53) 2.29 (1.56–3.36) 1.49 (0.96–2.31)
≥3 36 (20.96%) 3.30 (2.10–5.17) 3.03 (1.91–4.80) 1.50 (1.02–2.21)
P-trend <0.0001 <0.0001 0.0487
∗Model1:adjustedforage(years),race/ethnicity(non-Hispanicwhites,non-Hispanicblacks,andMexicanAmericans,others),education(belowhighschool,
high school, and above high school), smoking (never smoker, former smoker, and current smoker), and alcohol intake (absent, present).
†Model2:adjustedforage(years),race/ethnicity(non-Hispanicwhites,non-Hispanicblacks,andMexicanAmericans,others),education(belowhighschool,
highschool,abovehighschool),smoking(neversmoker,formersmoker,currentsmoker),alcoholintake(absent,present),physicalactivity(moderatephysical
activity), body mass index (obese, nonobese), depression (absent, present), diabetes (absent, present), and total cholesterol (mg/dL).
Table 4: Association between sleep variables and C-reactive protein levels > 1mg/dL, by race/ethnicity.
Sleep summary score Sample Size
(hypertension %)
Age-, sex-adjusted
odds ratio (95% CI)
Multivariable-model 1∗
odds ratio (95% CI)
Multivariable-model 2†
odds ratio (95% CI)
Non-Hispanic Whites
0 73 (5.55%) 1 (referent) 1 (referent) 1 (referent)
1 97 (7.87%) 1.59 (1.04–2.44) 1.54 (1.00–2.34) 1.23 (0.81–1.88)
2 71 (11.91%) 2.63 (1.80–3.85) 2.48 (1.66–3.68) 1.76 (1.14–2.72)
≥3 25 (14.09%) 3.24 (1.96–5.36) 2.79 (1.64–4.73) 1.62 (0.93–2.81)
P-trend <0.0001 <0.0001 0.0173
Non-Hispanic Blacks
0 48 (10.30%) 1 (referent) 1 (referent) 1 (referent)
1 62 (13.24%) 1.35 (0.82–2.22) 1.37 (0.82–2.28) 1.05 (0.61–1.80)
2 42 (14.02%) 1.52 (0.97–2.38) 1.55 (0.97–2.48) 0.96 (0.59–1.55)
≥3 10 (10.11%) 1.03 (0.42–2.49) 1.05 (0.43–2.56) 0.68 (0.29–1.60)
P-trend 0.2474 0.2032 0.4552
Mexican Americans and
others
0 32 (7.52%) 1 (referent) 1 (referent) 1 (referent)
1 53 (10.13%) 1.48 (1.00–2.18) 1.48 (0.98–2.22) 1.17 (0.75–1.83)
2 22 (10.42%) 1.58 (0.91–2.74) 1.53 (0.88–2.67) 1.17(0.64–2.13)
≥3 12 (24.46%) 4.40 (2.65–7.31) 4.21 (2.56–6.90) 2.96 (1.83–4.79)
P-trend <0.0001 <0.0001 <0.0001 0.0047
∗M o d e l1 :a d j u s t e df o ra g e( y e a r s ) ,g e n d e r( m a l e ,f e m a l e ) ,e d u c a t i o n( b e l o wh i ghs c h o o l ,h i ghs c h o o l ,a n da b o v eh i ghs c h o o l ) ,s m o k i n g( n ev e rs m o k e r ,f ormer
smoker, and current smoker) and alcohol intake (absent, present).
†M o d e l2 :a d j u s t e df o ra g e( y e a r s ) ,g e n d e r( m a l e ,f e m a l e ) ,e d u c a t i o n( b e l o whigh school, high school, and above high school), smoking (never smoker, former
smoker, and current smoker), alcohol intake (absent, present), physical activity (moderate physical activity), body mass index (obese, nonobese), depression
(absent, present), diabetes (absent, present), and total cholesterol (mg/dL).6 International Journal of Vascular Medicine
long sleep duration (>7 hours), occasional or frequent
snoring or snorting (>2 night/week), and daytime sleepiness
(>1/month) had moderately strong positive associations
with the presence of CRP levels > 1mg/dL in an initial
multivariable model adjusting for age, sex, race/ethnicity,
education, smoking, alcohol intake, and physical activity.
However, additional adjustment for potential mediating
factors such as BMI, depression, diabetes, hypertension, and
total cholesterol substantially attenuated this association.
Similarly, a summary SDB clustering score which counted
the co-occurrence of various SDB markers showed that,
when compared to those without SDB markers, those with
clustering of SDB markers were associated with higher odds
of having CRP levels > 1mg/dL in the initial multivariable
model. Here also the observed association was attenuated
with additional adjustment for physical activity, body mass
index, depression, diabetes, hypertension, and total choles-
terol.
In the subgroup analysis examining the association
between SDB clustering score and high CRP by gender,
there was only a weak association in men, but a mod-
erate association in women. In the subgroup analysis by
race/ethnicity, the association between SDB clustering score
and high CRP was strongly present in Mexican Americans,
modestly present with a signiﬁcant linear trend in Non-
Hispanic Whites and absent in Non-Hispanic Blacks.
CRP is a nonspeciﬁc inﬂammatory biomarker that has
been shown to be an important predictor of cardiovascular
disease [14, 25, 26]. Additionally, CRP is implicated in
inducting adhesion molecules, and the production of mono-
cyte chemoattractant protein-1 and sensitizing endothelial
cells to the cytotoxic process by CD4+T cells may also be an
active atherosclerotic pathogenic agent, in and of itself [12].
This study’s main contribution to the existing literature
concerning SDB is the demonstration in subgroup analyses
that the SDB-CRP association is strong in Mexican Amer-
icans in the race/ethnicity subgroup analysis and that it is
more strongly present in women in the gender subgroup
analysis. The ﬁnding implies that SDB has a residual, inde-
pendent association after the role of lifestyle and metabolic
risk factors such as BMI, lack of physical activity, depression,
diabetes, and total cholesterol in these subgroups.
The postulated mechanism of the association between
SDB and CRP is complex. SDB may have the eﬀects of
hypoxemia, reoxygenation, hypercapnia, and arousals which
activate systemic inﬂammation and the production of CRP
[27].
Similarstudieshavepresenteddisparateresultsinanalyz-
ing the associations of CRP and SDB. Our study is consistent
with a study of 69 men which indicated CRP is associated
with SDB independent of adiposity [1]. Another study of
316 men also found an association of SDB and increased
CRP, especially in men who were not overweight [15]. A
third study of 935 women with type 2 diabetes also indicated
SDB to be associated with increased CRP after adjusting
for age, BMI, lifestyle, family history of diabetes, glycemic
control, and medication use [28]. But a study utilizing the
Wisconsin Sleep Cohort Study of 907 participants reported
no association between CRP and SDB after controlling
for age, sex, and BMI [14]. Utilizing the same study,
but limiting the analysis to 589 women participants, SDB
was 2.6 times more likely to occur postmenopausally than
perimenopausally, after adjusting for age, body habitus, and
certain lifestyle factors [29], indicating a potential hormonal
inﬂuence associated with SDB. Our study will be largest to
date that examined the association between SDB markers
and CRP levels. We found that there was a modest positive
association, which, in subsequent subgroup analysis, was
found more strongly present in women and in Mexican
Americans. However, there is a need to examine the gender-
and race/ethnicity-speciﬁc associations between SDB and
markers of inﬂammation in larger studies and employing
alternative markers of inﬂammation such as interleukin-6
or tumor necrosis factor-alpha to prove or disprove our
ﬁndings.
Additionally, research is needed to determine if SDB
may be associated with chronic fatigue syndrome (CFS).
CFS results in prolonged (6 months or greater) disabling
daytime sleepiness and is associated with high levels of
proinﬂammatory markers [30]. The mechanism of CFS
appears to be an abnormal immunological response to an
antigen/infectionoraneuroendocrineproblemresultingina
change in the CNS, particularly in young adults [30]. Exam-
ining the role of SDB may provide greater understanding of
CFS.
This study’s strengths include the large and national
sample size of the study population and the breadth of the
national survey which included factors which we were able
touseaspotentialconfounders.Ourstudylimitationsarethe
cross-sectional nature of the national study (which prohibits
the making of causal inferences) and the self-reported nature
oftheSDBreports(whichhasthepotentialofnondiﬀerential
misclassiﬁcation which would bias the association to the
null).
In summary, this study shows that there is a positive
association of SDB markers to high CRP in a national
study of US adults, particularly for Mexican Americans and
moderately for women. Prospective studies are needed to
support the ﬁndings. These ﬁndings may be clinically useful
in determining interventions to improve sleep and maintain
lower levels of CRP.
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